Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthay

Showing results (1171-1180 of 1,339) with videos related to

Pageof 134
Sort By:
Science Translational Medicine|March 9, 2022
Pulmonary microbiome and gene expression signatures differentiate lung function in pediatric hematopoietic cell transplant candidatesMatt S Zinter, A Birgitta Versluys, Caroline A Lindemans, et al.
Science Advances|December 8, 2023
In vivo protein turnover rates in varying oxygen tensions nominate MYBBP1A as a mediator of the hyperoxia responseXuewen Chen, Augustinus G Haribowo, Alan H Baik, et al.
Critical Care Medicine|June 5, 2019
A Multicenter Study of the Causes and Consequences of Optimistic Expectations About Prognosis by Surrogate Decision-Makers in ICUsDouglas B White, Shannon Carson, Wendy Anderson, et al.
American Journal of Respiratory and Critical Care Medicine|June 21, 2008
Randomized clinical trial of activated protein C for the treatment of acute lung injuryKathleen D Liu, Joseph Levitt, Hanjing Zhuo, et al.
The European Respiratory Journal|April 2, 2021
Healthy <i>versus</i> inflamed lung environments differentially affect mesenchymal stromal cellsSara Rolandsson Enes, Thomas H Hampton, Jayita Barua, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 31, 2011
Altered lymphatics in an ovine model of congenital heart disease with increased pulmonary blood flowSanjeev A Datar, Eric G Johnson, Peter E Oishi, et al.
The New England Journal of Medicine|October 1, 2010
Outcome after reduced chemotherapy for intermediate-risk neuroblastomaDavid L Baker, Mary L Schmidt, Susan L Cohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology GroupKaci L Osenga, Jacquelyn A Hank, Mark R Albertini, et al.
Frontiers in Immunology|August 9, 2017
Epithelial Sodium Channel-α Mediates the Protective Effect of the TNF-Derived TIP Peptide in Pneumolysin-Induced Endothelial Barrier DysfunctionIstvan Czikora, Abdel A Alli, Supriya Sridhar, et al.
Cancer|July 15, 1997
A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer GroupJ D Frost, J A Hank, G H Reaman, et al.
Pageof 134

Showing results (1171-1180 of 1,339) with videos related to

Sort By:
Pageof 134
Science Translational Medicine|March 9, 2022
Pulmonary microbiome and gene expression signatures differentiate lung function in pediatric hematopoietic cell transplant candidatesMatt S Zinter, A Birgitta Versluys, Caroline A Lindemans, et al.
Science Advances|December 8, 2023
In vivo protein turnover rates in varying oxygen tensions nominate MYBBP1A as a mediator of the hyperoxia responseXuewen Chen, Augustinus G Haribowo, Alan H Baik, et al.
Critical Care Medicine|June 5, 2019
A Multicenter Study of the Causes and Consequences of Optimistic Expectations About Prognosis by Surrogate Decision-Makers in ICUsDouglas B White, Shannon Carson, Wendy Anderson, et al.
American Journal of Respiratory and Critical Care Medicine|June 21, 2008
Randomized clinical trial of activated protein C for the treatment of acute lung injuryKathleen D Liu, Joseph Levitt, Hanjing Zhuo, et al.
The European Respiratory Journal|April 2, 2021
Healthy <i>versus</i> inflamed lung environments differentially affect mesenchymal stromal cellsSara Rolandsson Enes, Thomas H Hampton, Jayita Barua, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 31, 2011
Altered lymphatics in an ovine model of congenital heart disease with increased pulmonary blood flowSanjeev A Datar, Eric G Johnson, Peter E Oishi, et al.
The New England Journal of Medicine|October 1, 2010
Outcome after reduced chemotherapy for intermediate-risk neuroblastomaDavid L Baker, Mary L Schmidt, Susan L Cohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology GroupKaci L Osenga, Jacquelyn A Hank, Mark R Albertini, et al.
Frontiers in Immunology|August 9, 2017
Epithelial Sodium Channel-α Mediates the Protective Effect of the TNF-Derived TIP Peptide in Pneumolysin-Induced Endothelial Barrier DysfunctionIstvan Czikora, Abdel A Alli, Supriya Sridhar, et al.
Cancer|July 15, 1997
A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer GroupJ D Frost, J A Hank, G H Reaman, et al.
Pageof 134